| Cash Flow for PDL BioPharma Inc. (PDLI) | | | | After Hours: $ 12.42 |  0.10 (+0.81%) | Volume: 14.08 k | 8:01 PM EDT Aug 28, 2008 | | | | | | | Cash Flow | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Net Income | (21,061) | (130,020) | (166,577) | (53,241) | (129,814) | | Depreciation & Amortization | 32,150 | 30,816 | 15,126 | 11,361 | 8,407 | | Deferred Income Taxes | - | - | - | - | - | | Operating Losses | 763 | 74 | 113,465 | 1,955 | 93,412 | | Extraordinary Losses | - | - | - | - | - | | | Decrease in Receivables | 10,821 | (1,080) | (24,150) | 340 | 2,975 | | Decrease in Inventories | (4,218) | (2,035) | 923 | - | - | | Decrease in Other Current Assets | 3,531 | 19,587 | (6,742) | 939 | (11,627) | | Increase in Payables | (4,585) | 10,750 | (4,029) | 1,277 | 997 | | Increase in Other Current Liabilities | (4,146) | 5,991 | 63,763 | 7,101 | 10,597 | | Decrease in Other Working Capital | (7,058) | (1,614) | - | 405 | - | | Other Non-Cash Items | 26,091 | 99,102 | - | (1,000) | - | | Net Cash from Continuing Operations | 66,973 | 78,770 | 31,550 | (27,156) | (22,965) | | Net Cash from Discontinued Operations | - | - | - | - | - | | Cash from Operating Activities | 66,973 | 78,770 | 31,550 | (27,156) | (22,965) | | | | Sale of Property, Plant, Equipment | 20,903 | 3,019 | - | - | - | | Sale of Short Term Investments | 291,083 | 308,759 | 154,536 | 146,777 | 278,000 | | | Purchase of Property, Plant, Equipment | (94,738) | (55,295) | (41,268) | (95,683) | (91,118) | | Acquisitions | - | - | (432,558) | - | - | | Purchase of Short Term Investments | (134,588) | (384,206) | (600) | (291,271) | (110,049) | | Other Investment Changes, Net | (10,005) | 11,731 | (873) | - | (98,369) | | Cash from Investing Activities | 72,655 | (115,992) | (320,763) | (240,177) | (21,536) | | | Issuance of Debt | - | - | 242,048 | - | 250,000 | | Issuance of Capital Stock | 27,273 | 33,529 | 139,868 | 18,313 | 4,110 | | | Repayment of Debt | (7,394) | (675) | (721) | (1,353) | (155,571) | | Repurchase of Capital Stock | - | - | - | - | - | | Payment of Cash Dividends | - | - | - | - | - | | Other Financing Charges, Net | 2,118 | - | - | - | - | | Cash from Financing Activities | 21,997 | 32,854 | 381,195 | 16,960 | 98,539 | | | | Effect of Exchange Rate Changes | - | - | - | - | - | | Net Change in Cash | 161,625 | (4,368) | 91,982 | (250,373) | 54,038 | | | Cash at Beginning of Year | 179,009 | 183,377 | 91,395 | 341,768 | 287,730 | | Cash at End of Period | 340,634 | 179,009 | 183,377 | 91,395 | 341,768 | | | |
